Increasing age is not associated with increasing fever and pneumonia after FOB, and chronological age should not be considered a limiting factor in the decision of whether to perform FOB when it is clinically indicated.

Abstract

No abstract

We described a 67 years old small-cell lung cancer patient with a prior history of idiopathic thrombocytopenic purpura (ITP) who was treated with successful chemotherapy. It is probably safe to administer chemotherapeutic agents for some cancer patients with prior history of ITP, but it is important to prevent or minimize the toxicities of these chemotherapeutic agents.